Andrew Palfreeman

Andrew Palfreeman has over 18 years of work experience in various roles in the field of scientific research and operations management.

Andrew is currently employed at Quell Therapeutics as the Senior Operations Support Manager, a role they have held since May 2022. Prior to this, they worked at the same company as the Lab Manager from November 2019 to May 2022.

From 2014 to 2019, Andrew worked at Barts Cancer Institute as the Laboratory Manager. In this role, they were responsible for managing the Centre for Molecular Oncology and Stem Cells in Cancer & Ageing. Their responsibilities included budgeting and grant management, recruitment, lab relocation, implementation of electronic lab notebook system, health and safety officer duties, and training staff and students, among other tasks.

Before joining Barts Cancer Institute, Andrew worked at the University of Oxford as a Senior Research Assistant from August 2011 to March 2014. In addition to contributing scientific research to the team's projects, they managed the day-to-day operations of the group, which consisted of 10 members. Andrew also coordinated the relocation of the research group from London to Oxford.

Prior to their role at the University of Oxford, Andrew worked at Imperial College London as a Graduate Research Assistant from October 2005 to August 2011. Their research focused on investigating the role of T cells in rheumatoid arthritis, and they collaborated with pharmaceutical companies such as Celgene and Roche. Their work resulted in scientific publications in peer-reviewed journals.

Andrew also has prior experience with GSK, where they completed a student internship from August 2003 to August 2004.

Andrew Palfreeman pursued their education in a chronological manner. From 2001 to 2005, they attended King's College London where they obtained a Bachelor of Science (BSc) degree with honors in Pharmacology With Toxicology. Moving forward, they enrolled at UCL from 2009 to 2011 and completed their Master of Science (MSc) degree in Experimental and Clinical Medicine. The field of study for both degrees is not specified. Additionally, Andrew Palfreeman has obtained a certification called "NEBOSH General Certificate" from the British Safety Council, although the details of when they obtained it are not provided.